Martinez-Mier Gustavo, Camargo-Diaz Cecilia, Urbina-Velazquez Marco Antonio, Avila-Pardo Sandro Fabricio
Department of Organ Transplantation, Hospital de Alta Especialidad de Veracruz, Veracruz, Mexico.
Department of Surgery, Hospital de Alta Especialidad de Veracruz, Veracruz, Mexico.
Ann Vasc Surg. 2020 Jan;62:304-309. doi: 10.1016/j.avsg.2019.06.034. Epub 2019 Aug 23.
An arteriovenous fistula (AVF) is the preferred vascular access for long-term hemodialysis. The main disadvantage of AVF is the rate of nonmaturation or unsuccessful use for hemodialysis (FUHD). We described our findings in AVF creation and possible risk factors associated with FUHD.
This is a retrospective study of AVFs during a 6-year period. Variables collected at the time of creation were demographics, comorbidities, replacement therapy, preoperative laboratory tests, and estimated 6-month mortality on hemodialysis. All AVFs were created in the upper arms. Outcomes were FUHD, cannulation failure, and cumulative survival. Univariate and multivariate analyses were performed to find possible risk factors for FUHD.
AVFs were created in 78 patients. Average age was 36.3 years, and 74.4% were male. Mean body mass index was 24.5 kg/m. The most common etiologies were glomerulopathy (53.6%) and diabetes mellitus (13.4%). Estimated six-month mortality was 4.2%. One patient underwent AVF before hemodialysis (mean dialysis time 2.2 years). Nineteen AVFs were considered FUHD (23.2%). Cannulation failure was 15.9%. AVF 1-year and 3-year survival was 67.8% and 63.5%, respectively. FUHD had higher estimated six-month mortality on hemodialysis, shorter prothrombin time, and lower serum albumin level than successful AVF (univariate analysis) (P < 0.05) Short prothrombin time and albumin were confirmed for FUHD (multivariate analysis). A 3.3-gr/dL serum albumin cutoff point (area under the curve, 0.715; receiver operating characteristic) (P < 0.05) was determined for FUHD.
The population referred for AVF creation possesses different characteristics in our center. Good AVF outcomes can be achieved. Preoperative serum albumin level and prothrombin time could be the possible risk factors associated with unsuccessful AVF use.
动静脉内瘘(AVF)是长期血液透析的首选血管通路。AVF的主要缺点是未成熟率或血液透析未成功使用率(FUHD)。我们描述了我们在AVF创建方面的发现以及与FUHD相关的可能危险因素。
这是一项对6年内的AVF进行的回顾性研究。创建时收集的变量包括人口统计学、合并症、替代治疗、术前实验室检查以及血液透析的估计6个月死亡率。所有AVF均在上臂创建。结局指标为FUHD、插管失败和累积生存率。进行单因素和多因素分析以寻找FUHD的可能危险因素。
78例患者创建了AVF。平均年龄为36.3岁,74.4%为男性。平均体重指数为24.5kg/m。最常见的病因是肾小球病(53.6%)和糖尿病(13.4%)。估计6个月死亡率为4.2%。1例患者在血液透析前进行了AVF创建(平均透析时间2.2年)。19个AVF被认为是FUHD(23.2%)。插管失败率为15.9%。AVF的1年和3年生存率分别为67.8%和63.5%。与成功的AVF相比,FUHD的血液透析估计6个月死亡率更高、凝血酶原时间更短且血清白蛋白水平更低(单因素分析)(P<0.05)。FUHD经多因素分析确认凝血酶原时间短和白蛋白低。确定了FUHD的血清白蛋白临界值为3.3g/dL(曲线下面积,0.715;受试者工作特征曲线)(P<0.05)。
在我们中心,接受AVF创建的人群具有不同特征。可以实现良好的AVF结局。术前血清白蛋白水平和凝血酶原时间可能是与AVF使用不成功相关的危险因素。